FDA Approves Cepheid's Meningitis PCR-Based Dx Test; Shares Spike 7 Percent

Mar 16, 2007

NEW YORK (GenomeWeb News) – The US Food and Drug Administration has cleared a Cepheid test designed to help physicians detect viral meningitis within two-and-a-half hours, the FDA said today.

News of the clearance caused shares in Cepheid to trade up 7 percent today at $9.22 in the mid-afternoon.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Last of the Northern White Rhinoceroses, Sequenced

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

DNA Phenotyping Allowed in Bavaria

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Thanks for the Stress, Dad

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

This Week in Science

In Science this week: gut microbiome influences liver cancer growth, spread; and more.

Main menu